title: Total hip arthroplasty with an uncemented tapered femoral component in patients younger than 50 years.
abstract: The purpose of the present study was to evaluate the outcome of primary uncemented total hip arthroplasty in patients younger than 50 years using the Taperloc (Biomet, Warsaw, Ind) femoral component. We evaluated 94 hips in 79 patients at a mean follow-up of 16 years (range, 11-18.5 years). The average age of the patients at the time of surgery was 36 years (range, 20-49 years). Three femoral components had been revised, none for aseptic loosening. Complete clinical and radiographic follow-up was obtained on the 91 hips that had not undergone femoral component revision. The mean Harris hip score increased from 54 points (range, 20-72) before surgery to 93 points (range, 68-100) at the time of this review. Radiographically, 89 stems (98%) were determined to have fixation by bone ingrowth, 2 (2%) demonstrated stable fibrous ingrowth, and no femoral component was loose. Distal femoral osteolysis was identified in 1 hip (1%). These findings indicate that excellent clinical and radiographic results can be achieved in young patients with the Taperloc femoral component at a mean follow-up of 16 years.
authors.affiliation: The Kennedy Center for the Hip and Knee @ Mercy Medical Center, Oshkosh, Wisconsin, USA.
authors.forename: Jeffrey R
authors.initials: JR
authors.lastname: McLaughlin
authors.forename: Kyla R
authors.initials: KR
authors.lastname: Lee
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000601:surgery; D019644:Arthroplasty, Replacement, Hip / Q000295:instrumentation*; D005260:Female; D005269:Femur / Q000000981:diagnostic imaging* / Q000601:surgery; D005271:Femur Head Necrosis / Q000601:surgery; D005500:Follow-Up Studies; D006618:Hip Dislocation, Congenital / Q000601:surgery; D006622:Hip Prosthesis / Q000592:standards*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015207:Osteoarthritis, Hip / Q000601:surgery*; D011474:Prosthesis Design / Q000592:standards*; D011859:Radiography; D016896:Treatment Outcome